K220891 is an FDA 510(k) clearance for the Kahook Dual Blade Glide (KDB Glide). Classified as Knife, Intraocular Pressure Lowering (product code QUQ), Class II - Special Controls.
Submitted by New World Medical, Inc. (Rancho Cucamonga, US). The FDA issued a Cleared decision on May 17, 2024 after a review of 781 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 878.4400 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Ophthalmic submissions.
View all New World Medical, Inc. devices